FDA Ushers in New Program for Drug Products Manufactured Using Innovative Manufacturing Technologies | King & Spalding
Under Section 3213 of Food and Drug Omnibus Reform Act, the U.S. Food & Drug Administration (“FDA” or the “Agency”) is required to establish the Advanced Manufacturing Technologies...
Source: jdsupra.com